Side-by-side comparison of AI visibility scores, market position, and capabilities
Leading government BPO and program administration firm. $5.43B FY2025 revenue. Runs Medicaid, Medicare, unemployment, and social-program eligibility for federal and state agencies globally.
Maximus is a global government services company founded in 1975 and headquartered in Tysons, Virginia. Trading on the NYSE (ticker: MMS), Maximus reported fiscal year 2025 revenue of $5.43 billion, up 2.4% year-over-year, providing outsourced business process management, program administration, and digital services to federal, state, and local government agencies across health, employment, student loans, and social assistance programs.\n\nThe company's services include eligibility determinations for Medicare, Medicaid, CHIP, and marketplace health insurance, unemployment insurance program administration, workforce development, tax credits processing, and benefits enrollment. Maximus operates in the United States, Australia, Canada, and the United Kingdom, processing millions of citizen interactions annually. Key technology capabilities include AI-powered contact center solutions, robotic process automation for claims adjudication, and digital intake platforms.\n\nMaximus has been expanding its digital technology portfolio to automate manual workflows in government programs, reduce fraud and improper payments, and improve citizen experience through omnichannel service delivery. The company plays a critical role administering large-scale healthcare and benefit programs, including the federal Marketplace enrollment support contract and state Medicaid eligibility operations. FY2026 revenue guidance is $5.225–$5.425 billion.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.